Community

Sylvain Marcel, Ph.D

Vice President of Protein Expression Sciences, iBio, Inc.

Dr. Marcel is a Senior Scientist in Molecular Biology and the Director of Early Stage Project Development at iBio CDMO. He received his Ph.D in plant cell and molecular biology at the RWTH University – Fraunhofer Institute, Aachen, Germany in 2006. Dr. Marcel joined the team of Dr. Barry Holtz in 2010 to develop and implement the midstream manufacturing protocols during the construction and operation of the biotherapeutics manufacturing facility in Bryan, Texas. As a senior scientist, Dr. Marcel optimized upstream and midstream manufacturing protocols and co-designed and operated the pilot-scale facility.

Community

Sylvain Marcel, Ph.D

Vice President of Protein Expression Sciences, iBio, Inc.

Contributions

The Advantages of Implementing Plant-Based Vaccines

Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine

The Advantage of Plant-Based Expression Solutions Around the Globe